North Fulton Dialysis is a medicare approved dialysis facility center in Roswell, Georgia and it has 9 dialysis stations. It is located in Fulton county at 1250 North Meadow Pkwy, Roswell, GA, 30076. You can reach out to the office of North Fulton Dialysis at (770) 569-2888. This dialysis clinic is managed and/or owned by Davita. North Fulton Dialysis has the following ownership type - Profit. It was first certified by medicare in October, 1995. The medicare id for this facility is 112617 and it accepts patients under medicare ESRD program.
| Name | North Fulton Dialysis |
|---|---|
| Location | 1250 North Meadow Pkwy, Roswell, Georgia |
| No. of Dialysis Stations | 9 |
| Medicare ID | 112617 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1250 North Meadow Pkwy, Roswell, Georgia, 30076 | |
| (770) 569-2888 | |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
| NPI Number | 1134197296 |
| Organization Name | North Fulton Dialysis |
| Doing Business As | Dva Renal Healthcare Inc |
| Address | 1250 N Meadow Pkwy Roswell, Georgia, 30076 |
| Phone Number | (770) 569-2888 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 61% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 19% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 20% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 63% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 14% |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 48% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 21% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 31% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 42% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 12% |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 71% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 29% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 42% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 33% | 12% |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 36 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 8 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 65 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 501 |
| Percentage of adult patients getting regular hemodialysis at the center | 88 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 14 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 150 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 99 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at North Fulton Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 82 |
| Hypercalcemia patient months | 691 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 81 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 37 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 19 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 72 |
| Patient months included in arterial venous fistula and catheter summaries | 431 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 66 |
| Hospitalization Rate in facility | 146.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 289.7 |
| Hospitalization Rate: Lower Confidence Limit | 76.4 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at North Fulton Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 14.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 25.7 |
| Readmission Rate: Lower Confidence Limit | 6.4 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at North Fulton Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .91 (As Expected) |
| SIR: Upper Confidence Limit | 2.47 |
| SIR: Lower Confidence Limit | .23 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether North Fulton Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 60 |
| Transfusion Rate in facility | 31 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 100.6 |
| Transfusion Rate: Lower Confidence Limit | 11 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at North Fulton Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 363 |
| Mortality Rate in facility | 15.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.5 |
| Mortality Rate: Lower Confidence Limit | 10.9 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago
Dialysis America Inc Alpharetta Dialysis Center Location: 1260 Upper Hembree Road, Roswell, Georgia, 30076 Phone: (770) 751-9757 |
Renal Care Partners Of Roswell Location: 11660 Alpharetta Hwy, Suite 650, Roswell, Georgia, 30076 Phone: (678) 710-0970 |
News Archive
Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies.
Loyola University Medical Center ophthalmologist Charles Bouchard, MD, is being honored by the Illinois Eye Bank for his commitment to the eye bank's efforts and mission.
Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
› Verified 5 days ago